JohnF.De GrootMD

PubMed

• An expedited strategy for accurate and timely integrated molecular diagnosis of gliomas.
  Timothy A Gregory, Garret L Williford, Jacob M Maronge, Kristin Alfaro, Gregory N Fuller, John de Groot, Vinay K Puduvalli, Leomar Y Ballester, Nazanin K Majd> ;Neuro-Oncology. 2023 Apr 6
• 4 citations
  Preclinical Models of Low-Grade Gliomas.
  Pushan Dasgupta, Veerakumar Balasubramanyian, John F de Groot, Nazanin K Majd> ;Cancers. 2023 Jan 18
• 10 citations
  Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.
  Benjamin M Ellingson, Patrick Y Wen, Susan M Chang, Martin van den Bent, Michael A Vogelbaum, Gang Li, Shanpeng Li, Jiyoon Kim, Gilbert Youssef, Wolfgang Wick, Andrew ...> ;Neuro-Oncology. 2023 Jun 2
• 9 citations
  Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.
  Calixto-Hope G Lucas, Emily A Sloan, Rohit Gupta, Jasper Wu, Drew Pratt, Harish N Vasudevan, Ajay Ravindranathan, Jairo Barreto, Erik A Williams, Anny Shai, Nicholas S...> ;Acta Neuropathologica. 2022 Oct 1
• Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis.
  Rituraj Upadhyay, Swapnil Khose, Halyna Pokhylevych, Arnold C Paulino, Mary Frances McAleer, Amol Ghia, Jing Li, Debra Nana Yeboa, Monica Loghin, Rebecca Harrison, Bar...> ;Neuro-Oncology Advances. 2022 Aug 20
• 6 citations
  Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.
  C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, Igor J Barani, Steve Braunstein, Joseph A Bovi, Jo...> ;Neuro-Oncology. 2023 Jan 5
• 19 citations
  Liquid biopsy in gliomas: A RANO review and proposals for clinical applications.
  Riccardo Soffietti, Chetan Bettegowda, Ingo K Mellinghoff, Katherine E Warren, Manmeet S Ahluwalia, John F De Groot, Evanthia Galanis, Mark R Gilbert, Kurt A Jaeckle, ...> ;Neuro-Oncology. 2022 Jun 1
• Molecular, Histological, and Clinical Characteristics of Oligodendrogliomas: A Multi-Institutional Retrospective Study.
  Antonio Dono, Kristin Alfaro-Munoz, Yuanqing Yan, Carlos A Lopez-Garcia, Zaid Soomro, Garret Williford, Takeshi Takayasu, Lindsay Robell, Nazanin K Majd, John de Groot...> ;Neurosurgery. 2022 May 1
• 19 citations
  Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrentwild-type glioblastoma.
  John F de Groot, Albert H Kim, Sujit Prabhu, Ganesh Rao, Adrian W Laxton, Peter E Fecci, Barbara J O'Brien, Andrew Sloan, Veronica Chiang, Stephen B Tatter, Alireza M ...> ;Neuro-Oncology Advances. 2022 Apr 6
• 3 citations
  Clinical and survival characteristics of primary and secondary gliosarcoma patients.
  Ahmad Amer, Swapnil Khose, Hamza Alhasan, Halyna Pokhylevych, Greg Fuller, Noah Chasen, John de Groot, Jason M Johnson> ;Clinical Neurology and Neurosurgery. 2022 Mar 1
• 2 citations
  Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma.
  Evanthia Galanis, Patrick Y. Wen, John F de Groot, Michael Weller> ;Hematology/oncology Clinics of North America. 2022 Feb 1
• 5 citations
  Imaging Primer on Chimeric Antigen Receptor T-Cell Therapy for Radiologists.
  Patricia M de Groot, Octavio Arevalo, Komal Shah, Chad D Strange, Girish S Shroff, Jitesh Ahuja, Mylene T Truong, John F de Groot, Ioannis Vlahos> ;Radiographics. 2022 Jan 6
• 6 citations
  Aggressiveness of care at end of life in patients with high-grade glioma.
  Rebecca Harrison, Alexander Ou, Syed Naqvi, Syed Mujtaba Ali Naqvi, Shiao Pei Weathers, Barbara O’Brien, John de Groot, Eduardo Bruera> ;Cancer Medicine. 2021 Nov 9
• 10 citations
  Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells
  Sabbir Khan, Rajasekaran Mahalingam, Shayak Sen, Emmanuel Martinez-Ledesma, Arshad Khan, Kaitlin Gandy, Frederick F. Lang, Erik P. Sulman, Kristin Alfaro-Munoz, Nazani...> ;Cancers. 2021 Oct 21
• 3 citations
  IDH mutation status and the development of venous thromboembolism in astrocytoma patients.
  Jacob Mandel, Michael Youssef, Shlomit Yust-Katz, Akash J. Patel, Ali Jalali, Ziyi Li, Jimin Wu, Ethan B. Ludmir, John de Groot> ;Journal of the Neurological Sciences. 2021 Aug 15
• 47 citations
  Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.
  Aria Sabbagh, Kevin Beccaria, Xiaoyang Ling, Anantha Marisetty, Martina Ott, Hillary G. Caruso, Emily Barton, Ling Yuan Kong, Dexing Fang, Khatri Latha, Daniel Yang Zh...> ;Clinical Cancer Research. 2021 Aug 1
• 20 citations
  Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine
  Yasaman Barekatain, Jeffrey J. Ackroyd, Victoria C. Yan, Sunada Khadka, Lin Wang, Ko Chien Chen, Anton H. Poral, Theresa Tran, Dimitra K. Georgiou, Kenisha Arthur, Yu ...> ;Nature Communications. 2021 Jul 9
• 7 citations
  Report of National Brain Tumor Society Roundtable Workshop on Innovating Brain Tumor Clinical Trials: Building on Lessons Learned from COVID-19 Experience.
  Eudocia Q. Lee, Wendy Selig, Clair Meehan, Jeffrey A. Bacha, Amy Barone, Erik Bloomquist, Susan M. Chang, John de Groot, Evanthia Galanis, Islam Hassan, Chitkala Kalid...> ;Neuro-Oncology. 2021 Apr 2
• 38 citations
  A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.
  Paul D. Brown, Caroline Chung, Diane D. Liu, Sarah McAvoy, David R. Grosshans, Karine A. Al Feghali, Anita Mahajan, Jing Li, Susan L. McGovern, M.F. McAleer, Amol J. G...> ;Neuro-Oncology. 2021 Aug 2
• 106 citations
  Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma.
  Lakshmi Nayak, Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot, Leia Nghiemphu, Thomas Kaley, Howard Colman, Christine McClu...> ;Clinical Cancer Research. 2021 Feb 15
• 50 citations
  PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma.
  Shaofang Wu, Xiao-Long Li, Feng Gao, John de Groot, Dimpy Koul, W. K. Alfred Yung> ;Neuro-Oncology. 2021 Jun 1
• 18 citations
  The promise of DNA damage response inhibitors for the treatment of glioblastoma.
  Nazanin Majd, Timothy A. Yap, Dimpy Koul, Veerakumar Balasubramaniyan, Xiao-Long Li, Sabbir Khan, Katilin S Gandy, W. K. Alfred Yung, John de Groot> ;Neuro-Oncology Advances. 2021 Jan 1
• 25 citations
  Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.
  Kevin Beccaria, Aria Sabbagh, John de Groot, Michael Canney, Alexandre Carpentier, Amy B. Heimberger> ;Journal of Neuro-Oncology. 2021 Jan 1
• 1 citations
  Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment.
  Karine A. Al Feghali, J.W. Randall, Diane D. Liu, Jeffrey S. Wefel, Paul D. Brown, David R. Grosshans, Sarah McAvoy, Maguy A Farhat, Jing Li, Susan L. McGovern, Mary F...> ;Neuro-Oncology Advances. 2021 Jan 1
• 2 citations
  Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastoma.
  Benjamin M. Ellingson, Kunal S. Patel, Chencai Wang, Catalina Raymond, Andrew Brenner, John de Groot, Nicholas Butowski, Leor Zach, Jian Campian, Jacob Schlossman, Sha...> ;Neuro-Oncology Advances. 2021 Jan 1
• Join now to see all

Lectures

• Window-of-opportunity clinical trial of a PD-1 inhibitor in patients with recurrent glioblastoma. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018